<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03644147</url>
  </required_header>
  <id_info>
    <org_study_id>H-1807-151-961</org_study_id>
    <nct_id>NCT03644147</nct_id>
  </id_info>
  <brief_title>Additive Effect of Intravenous Acetaminophen on Postoperative Pain Control</brief_title>
  <official_title>Additive Effect of Intravenous Acetaminophen Administered at the End of Surgery on Postoperative Pain Control With Nefopam and Fentanyl-based Patient-controlled Analgesia: A Double-blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the additive effect of acetaminophen on postoperative pain
      control in patients receiving nefopam and fentanyl-based patient-controlled analgesia.

      Participants undergoing laparoscopic hysterectomy will be randomly assigned to treatment
      group or control group. After end of surgery, acetaminophen or normal saline (placebo) will
      be administered intravenously depending on the group assigned.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2018</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double-blind randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total volume of administered analgesics during postoperative 24 hours</measure>
    <time_frame>24 hours</time_frame>
    <description>morphine equivalent dose of patient-controlled analgesics administered during first 24 hours after end of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>24 hours</time_frame>
    <description>11-point numeric rating scale ranging from '0' representing one pain extreme (e.g. &quot;no pain&quot;) to '10' representing the other pain extreme (e.g. &quot;pain as bad as you can imagine&quot; or &quot;worst pain imaginable&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score</measure>
    <time_frame>24 hours</time_frame>
    <description>11-point numeric rating scale ranging from '0' representing one extreme (e.g. &quot;extremely dissatisfied&quot;) to '10' representing the other extreme (e.g. &quot;extremely satisfied&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>4-scales scoring (none; mild; moderate; severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid-related adverse effect</measure>
    <time_frame>24 hours</time_frame>
    <description>Incidence of respiratory, gastrointestinal, and central nervous system complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of alternative analgesics</measure>
    <time_frame>24 hours</time_frame>
    <description>Additional administration of other analgesics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>From date of hospital admission until the date of discharge, an average of 1 week</time_frame>
    <description>Hospital length of stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Gynecologic Disease</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will receive 1 gram of acetaminophen intravenously after the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will receive 100 ml of normal saline intravenously after the end of surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Acetaminophen will be intravenously administrated to treatment group after the end of surgery.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing total laparoscopic hysterectomy due to uterine myoma, cervical
             cancer, endometriosis, uterine prolapse

        Exclusion Criteria:

          -  Liver disease (aspartate transaminase OR alanine transaminase &gt; 80 IU/L)

          -  Chronic kidney disease (GFR &lt; 30 ml/min/1.73m2)

          -  History of drug allergy

          -  Chronic pain lasting more than 3 months

          -  Conversion to laparotomy

          -  Complex surgery (co-operation with colon surgeon or urologist)

          -  Limitation in expressing pain
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, Pf.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Tae Kim, M.D., Ph.D.</last_name>
    <phone>+82-2-2072-3592</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, M.D., Ph.D.</last_name>
      <phone>+82-2-2072-3664</phone>
      <email>jintae73@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 21, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2018</study_first_posted>
  <last_update_submitted>July 7, 2019</last_update_submitted>
  <last_update_submitted_qc>July 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genital Diseases, Female</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

